Debt to Equity Ratio Chart

View Debt to Equity Ratio for AQST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -2.635
March 31, 2026 -3.922
December 31, 2025 -3.905
September 30, 2025 -31.36
June 30, 2025 -1.739
March 31, 2025 -2.044
December 31, 2024 -2.027
September 30, 2024 -2.630
June 30, 2024 -3.294
March 31, 2024 -3.172
December 31, 2023 -0.928
September 30, 2023 -1.064
June 30, 2023 -1.027
March 31, 2023 -1.041
December 31, 2022 -1.035
September 30, 2022 -1.116
June 30, 2022 -1.238
March 31, 2022 -1.277
Date Value
December 31, 2021 -1.421
September 30, 2021 -1.689
June 30, 2021 -1.808
March 31, 2021 -1.810
December 31, 2020 -1.844
September 30, 2020 -1.802
June 30, 2020 -3.059
March 31, 2020 -3.118
December 31, 2019 -9.856
September 30, 2019 -1.735
June 30, 2019 -1.924
March 31, 2019 -7.859
December 31, 2018 4.683
September 30, 2018 1.996
June 30, 2018 -1.192
March 31, 2018 -2.052
December 31, 2017 -1.718

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
LENZ Therapeutics, Inc. 0.0026
ANI Pharmaceuticals, Inc. 1.022
Corcept Therapeutics, Inc. 0.0133
Veru, Inc. 0.0945
Johnson & Johnson 0.5771

Debt to Equity Ratio Related Metrics